InsidersTradesSigma
Ortivus AB Stock: price and management transactions · Finland · FIN-FSA
Follow the Ortivus AB stock price and the full management transaction log of the company, a publicly traded company based in Finland. Shares are listed on FI FI, under the oversight of FIN-FSA. Operating in the Health Care sector, Ortivus AB has published 21 public disclosures. Market capitalisation: €150.6m. The latest transaction was reported on 24 June 2026 (Purchase). Among the most active insiders: Peter Edwall. The full history is accessible without an account.
21
Insider Decl.
0
Thresholds
€64,039
10 ops.
Buy Volume
·
0 ops.
Sell Volume
47Σ signal
Fundamental score
Ranked 23,417 of 25,927 companies
21.5
score / 100
Value11
Quality32
FCF yld-23%
Earn yld-14%
EV/EBITDA·
ROE·
Gross mgn40%
Net mgn-30%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 24 June 2026
Declarations21 total
1,000,000 shares@ SEK 0.300.017% mcap100.0% of flowOptionFI:csv-073975f4d61ed1fdcc00
Ideal exit: 21 Mar 2027 (T+270)
1,000,000 shares@ SEK 0.300.017% mcap30.4% of flowKöpoptionFI:csv-bac9454a7157e3763308
50,000 shares@ SEK 0.300.0009% mcap2.2% of flowKöpoptionFI:csv-46ec0d337d057fab4661
50,000 shares@ SEK 0.300.0009% mcap16.6% of flowKöpoptionFI:csv-09f72c96a7bba2ea4903
Ideal exit: 5 Mar 2027 (T+270)
50,000 shares@ SEK 0.300.0009% mcap2.2% of flowKöpoptionFI:A003Z821-1
50,000 shares@ SEK 0.300.0009% mcap16.6% of flowKöpoptionFI:A003Z816-1
Ideal exit: 5 Mar 2027 (T+270)
100,000 shares@ SEK 0.300.0017% mcap33.4% of flowKöpoptionFI:csv-733901f3a24d5db06f4c
Ideal exit: 26 Feb 2027 (T+270)
100,000 shares@ SEK 0.300.0017% mcap100.0% of flowKöpoptionFI:A003Z562-1
Ideal exit: 26 Feb 2027 (T+270)
100,000 shares@ SEK 0.300.0017% mcap4.5% of flowKöpoptionFI:csv-50ff358af01f2bd8d2ee
75,000 shares@ SEK 0.300.0013% mcap3.3% of flowKöpoptionFI:csv-787024ede958db95ba54
100,000 shares@ SEK 0.300.0017% mcap17.4% of flowKöpoptionFI:A003Z495-1
75,000 shares@ SEK 0.300.0013% mcap13.1% of flowKöpoptionFI:A003Z493-1
75,000 shares@ SEK 0.300.0013% mcap50.0% of flowKöpoptionFI:csv-64c3d7a378419b2ddc28
Ideal exit: 26 Feb 2027 (T+270)
75,000 shares@ €0.02760.0013% mcap100.0% of flowKöpoptionFI:A003Z422-1
Ideal exit: 26 Feb 2027 (T+270)
600,000 shares@ SEK 0.200.0069% mcap17.8% of flowOptionFI:csv-af356bb9c275fc3734d8
600,000 shares@ €0.01840.0069% mcap100.0% of flowOptionFI:A003Y298-2
20,145 shares@ SEK 2.9013.4% of flowAktieFI:A001P470-1
75,545 shares@ SEK 2.9087.7% of flowAktieFI:A001P374-1
Ideal exit: 2 Oct 2021 (T+270)
75,545 shares@ SEK 2.9050.0% of flowAktieFI:A001P349-1
2,600 shares@ SEK 5.285.5% of flowAktieFI:A001P324-1
Ideal exit: 1 Oct 2021 (T+270)
3,471 shares@ SEK 4.886.8% of flowAktieFI:A001P323-1
Ideal exit: 24 Sept 2021 (T+270)
21 of 21 declarations
About Ortivus AB
Ortivus AB is a Swedish company specializing in health and pharmaceutical solutions. It is listed on the Stockholm Stock Exchange (XSTO).